Author/Editor     Bastelica, D; Mavri, A; Verdierl, M; Berthet, B; Juhan-Vague, I; Alessi, MC
Title     Relationships between fibrinolytic and inflammatory parameters in human adipose tissue: strong contribution of TNFalpha receptors to PAI-1 levels
Type     članek
Source     Thromb Haemost
Vol. and No.     Letnik 88, št. 3
Publication year     2002
Volume     str. 481-7
Language     eng
Abstract     Plasminogen activator inhibitor type 1 (PAI-1), a risk marker of atherosclerosis, is highly expressed in adipose tissue from obese subjects. PAI-1 is also considered as an acute phase protein. Recently, adipose tissue has been described as a source of inflammatory cytokines. Therefore, our aim was to study the relationships between PAI-1, and IL-6, TNF, TNF receptors (TNFRSF1s) and TGFbeta1, in plasma and adipose tissue from obese (n = 60) and lean (n = 28) subjects. Study has been extended to plasminogen activators (t-PA and u-PA). Compared to lean subjects, obese subjects exhibited higher plasma levels of all the studied parameters (except for TGFbeta1) whereas in adipose tissue only PAI-1, t-PA and TGFbeta antigen levels differed. In the obese population, plasma PAI-1 levels were weakly associated with circulating TNF, and this relationship disappeared after adjustment for plasma t-PA. Adipose tissue PAI-1 levels were positively associated with TNFRSF1s and TGFbeta, the strongest relationship being observed with TNFRSF1A, which explained 82% of PAI-1 variability. TNF and IL-6 were the main contributors to t-PA variability in plasma and in adipose tissue, respectively. Our results argue on the relevance of TNFRSF1s in the regulation of PAI-1 expression by adipose tissue. Association between t-PA, which is mainly produced by endothelial cells, and IL-6 or TNF suggest that inflammation might be involved in angiogenesis in adipose tissue.
Descriptors     ADIPOSE TISSUE
ADULT
ANTIGENS, CD
BIOLOGICAL MARKERS
CASE-CONTROL STUDIES
FIBRINOLYSIS
INFLAMMATION
INTERLEUKIN-6
OBESITY
PLASMINOGEN ACTIVATOR INHIBITOR 1
RECEPTORS, TUMOR NECROSIS FACTOR